Catalog No.
RHN05801
Species reactivity
Human
Host species
Mouse
Isotype
IgG2a, kappa
Clonality
Monoclonal
Target
Equilibrative nucleoside transporter 1, Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter, Solute carrier family 29 member 1, SLC29A1, Nucleoside transporter, es-type, Equilibrative NBMPR-sensitive nucleoside transporter, ENT1
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q99808
Applications
ELISA
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
SAA1893
Enhancing protein productivities in CHO cells through adenosine uptake modulation - Novel insights into cellular growth and productivity regulation., PMID:39151888
A review of the Augustine blood group system., PMID:38767828
Combination of Tissue Microarray Profiling and Multiplexed IHC Approaches to Investigate Transport Mechanism of Nucleoside Analog Drug Resistance., PMID:37191793
Molecular and structural characterization of a novel high-prevalence antigen of the Augustine blood group system., PMID:36744388
Augustine Blood Group System and Equilibrative Nucleoside Transporter 1., PMID:35221865
Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy., PMID:34388391
MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans., PMID:33485947
Transcriptomics of atopy and atopic asthma in white blood cells from children and adolescents., PMID:30923181
Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance)., PMID:29871907
Synthetic single domain antibodies for the conformational trapping of membrane proteins., PMID:29792401
The Augustine blood group system, 48 years in the making., PMID:27834482
The antibodies against 5-bromo-2'-deoxyuridine specifically recognize trifluridine incorporated into DNA., PMID:27137226
Expression, purification and functional characterization of human equilibrative nucleoside transporter subtype-1 (hENT1) protein from Sf9 insect cells., PMID:26162242
Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine - Results from the CONKO-001 trial., PMID:26049689
Type 1 equilibrative nucleoside transporter regulates astrocyte-specific glial fibrillary acidic protein expression in the striatum., PMID:25365803
Human equilibrative nucleoside transporter 1 testing in pancreatic ductal adenocarcinoma: a comparison between murine and rabbit antibodies., PMID:25298108
Human equilibrative nucleoside transporter 1 is not predictive for gemcitabine efficacy in advanced pancreatic cancer: translational results from the AIO-PK0104 phase III study with the clone SP120 rabbit antibody., PMID:24857044
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial., PMID:24301456
Behavioral effects of elevated expression of human equilibrative nucleoside transporter 1 in mice., PMID:21645551
Ribonucleotide reductase subunit M1 assessed by quantitative double-fluorescence immunohistochemistry predicts the efficacy of gemcitabine in biliary tract carcinoma., PMID:20811706
Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients., PMID:20578816
The absence of human equilibrative nucleoside transporter 1 expression predicts nonresponse to gemcitabine-containing chemotherapy in non-small cell lung cancer., PMID:17658213
Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney., PMID:17409283
Localization of the NBMPR-sensitive equilibrative nucleoside transporter, ENT1, in the rat dorsal root ganglion and lumbar spinal cord., PMID:16226730
The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma., PMID:15501974
Efficient labeling of fission yeast Schizosaccharomyces pombe with thymidine and BUdR., PMID:14576334
Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers., PMID:12912975
Control of glutamatergic neurotransmission in the rat spinal dorsal horn by the nucleoside transporter ENT1., PMID:12611914
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia., PMID:12411296
Differential expression of human equilibrative nucleoside transporter 1 (hENT1) protein in the Reed-Sternberg cells of Hodgkin's disease., PMID:12389626
Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers., PMID:11801546
Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system., PMID:11311901
For research use only. Not for human or drug use.
